EUVIMEDEUVIMED entdecken
Crossref

Pirfenidone alleviates chronic pancreatitis via suppressing the activation of pancreatic stellate cells and the M1 polarization of macrophages

Hong-Lei Guo, Xue-Song Liang, Xiang-Peng Zeng, Yu Liu, Zhao-Shen Li, Li-Juan Wang, Liang-Hao Hu

International Immunopharmacology · 2024-03 · 130 · 111691

DOI: 10.1016/j.intimp.2024.111691 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2024-03. Verfasst von Hong-Lei Guo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, First Affiliated Hospital of Naval Medical University, Shanghai, China; Shanghai Institute of Pancreatic Diseases,…. Hauptthemen laut MEDLINE: Pancreatic Stellate Cells, Pancreatitis, Chronic, Pyridones. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the realm of fibroinflammatory conditions, chronic pancreatitis (CP) stands out as a particularly challenging ailment, lacking a dedicated, approved treatment. The potential of Pirfenidone (PFD), a drug originally used for treating idiopathic pulmonary fibrosis (IPF), in addressing CP's fibrotic aspects has sparked new interest. This investigation focused on the role of PFD in diminishing fibrosis and immune response in CP, using a mouse model induced by caerulein. The research extended to in vitro studies examining the influence of PFD on pancreatic stellate cells' (PSCs) behavior and the polarization of macrophages into M1 and M2 types. Advanced techniques like RNA sequencing and comprehensive data analyses were employed to decode the molecular interactions of PFD with PSCs. Supplementary experiments using techniques such as quantitative real-time PCR, western blotting, and immunofluorescence were also implemented. Results showed a notable reduction in pancreatic damage in PFD-treated mice, manifested through decreased acinar cell atrophy, lower collagen deposition, and a reduction in macrophage presence. Further investigation revealed PFD's capacity to hinder PSCs' migration, growth, and activation, alongside a reduction in the production and secretion of extracellular matrix proteins. This effect is primarily achieved by interfering with signaling pathways such as TGF-β/Smad, Wnt/β-catenin, and JAK/STAT. Additionally, PFD selectively hampers M1 macrophage polarization through the STAT3 pathway, without impacting M2 polarization. These outcomes highlight PFD's dual mechanism in moderating PSC activity and M1 macrophage polarization, positioning it as a promising candidate for CP therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic Stellate CellsPancreatitis, ChronicPyridonesHumansPancreasMacrophagesFibrosis

Stichwörter der Autor:innen

Chronic pancreatitisFibrosisMacrophagePancreatic stellate cellPirfenidone

Substanzen

pirfenidonePyridones

Autor:innen und Institutionen

  • Department of Infectious Diseases, First Affiliated Hospital of Naval Medical University, Shanghai, China; Shanghai Institute of Pancreatic Diseases, Shanghai, China.
  • Department of Infectious Diseases, First Affiliated Hospital of Naval Medical University, Shanghai, China.
  • Department of Digestive Diseases, No. 900 Hospital of the Joint Logistics Support Force, Fuzhou, Fujian, China.
  • Department of Gastroenterology and Hepatology, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, China.
  • Shanghai Institute of Pancreatic Diseases, Shanghai, China; Department of Gastroenterology, First Affiliated Hospital of Naval Medical University, Shanghai, China.
  • Shanghai Institute of Pancreatic Diseases, Shanghai, China; Department of Gastroenterology, First Affiliated Hospital of Naval Medical University, Shanghai, China. Electronic address: wanglijuan586@163.com.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Guo, H. L., Liang, X. S., Zeng, X. P., Liu, Y., Li, Z. S., Wang, L. J., & Hu, L. H. (2024). Pirfenidone alleviates chronic pancreatitis via suppressing the activation of pancreatic stellate cells and the M1 polarization of macrophages. International Immunopharmacology, 130, 111691. https://doi.org/10.1016/j.intimp.2024.111691

Vancouver

Guo HL, Liang XS, Zeng XP, Liu Y, Li ZS, Wang LJ, et al. Pirfenidone alleviates chronic pancreatitis via suppressing the activation of pancreatic stellate cells and the M1 polarization of macrophages. International Immunopharmacology. 2024;130:111691. doi:10.1016/j.intimp.2024.111691

BibTeX
@article{Guo2024,
  author = {Guo, Hong-Lei and Liang, Xue-Song and Zeng, Xiang-Peng and Liu, Yu and Li, Zhao-Shen and Wang, Li-Juan and Hu, Liang-Hao},
  title = {Pirfenidone alleviates chronic pancreatitis via suppressing the activation of pancreatic stellate cells and the M1 polarization of macrophages},
  journal = {International Immunopharmacology},
  year = {2024},
  volume = {130},
  pages = {111691},
  doi = {10.1016/j.intimp.2024.111691}
}
Kostenlos starten →